DENTSPLY SIRONA Files Additional Proxy Materials

TL;DR

DENTSPLY SIRONA dropped more proxy docs, likely for shareholder votes. Nothing major new, just extra info.

AI Summary

DENTSPLY SIRONA Inc. filed a Definitive Additional Materials proxy statement on April 14, 2025. This filing relates to the company's proxy materials, which are used to solicit votes from shareholders for upcoming meetings. The filing does not appear to contain new proposals or significant changes but rather additional information or clarifications related to previously distributed proxy materials.

Why It Matters

This filing indicates that DENTSPLY SIRONA is providing supplementary information to its shareholders regarding proxy voting, which is crucial for corporate governance and shareholder participation in company decisions.

Risk Assessment

Risk Level: low — The filing is a routine proxy statement supplement, not indicating any immediate financial or operational risks.

Key Players & Entities

• DENTSPLY SIRONA Inc. (company) — Registrant
• 0001140361-25-013627 (filing_id) — Accession Number
• 20250414 (date) — Filing Date

FAQ

From the Filing

0001140361-25-013627.txt : 20250414 0001140361-25-013627.hdr.sgml : 20250414 20250414080049 ACCESSION NUMBER: 0001140361-25-013627 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20250414 DATE AS OF CHANGE: 20250414 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DENTSPLY SIRONA Inc. CENTRAL INDEX KEY: 0000818479 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 391434669 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 000-16211 FILM NUMBER: 25834242 BUSINESS ADDRESS: STREET 1: 13320 BALLANTYNE CORPORATE PLACE CITY: CHARLOTTE STATE: NC ZIP: 28277-3607 BUSINESS PHONE: 844-546-3722 MAIL ADDRESS: STREET 1: 13320 BALLANTYNE CORPORATE PLACE CITY: CHARLOTTE STATE: NC ZIP: 28277-3607 FORMER COMPANY: FORMER CONFORMED NAME: DENTSPLY INTERNATIONAL INC /DE/ DATE OF NAME CHANGE: 19930630 FORMER COMPANY: FORMER CONFORMED NAME: GENDEX CORP DATE OF NAME CHANGE: 19920703 DEFA14A 1 ny20039969x4_defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934         Filed by the Registrant ☒     Filed by a Party other than the Registrant   ☐         Check the appropriate box:   ☐ Preliminary Proxy Statement   ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))   ☐ Definitive Proxy Statement ☒ Definitive Additional Materials   ☐ Soliciting Material Under §240.14a-12   DENTSPLY SIRONA Inc. (Name of Registrant as Specified In Its Charter)     (Name of Person(s) Filing Proxy Statement, if other than the Registrant)   Payment of Filing Fee (Check the boxes that apply): ☒ No fee required.   ☐ Fee paid previously with preliminary materials.   ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.                       DENTSPLY SIRONA INC. 13320 Ballantyne Corporate Place Charlotte, NC 28277         SUPPLEMENT TO PROXY STATEMENT FOR 2025 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON WEDNESDAY, MAY 21, 2025 EXPLANATORY NOTE On April 9, 2025, DENTSPLY SIRONA Inc. (the “Company”) filed a definitive proxy statement (the “Proxy Statement”) for its 2025 Annual Meeting of Stockholders (the “Annual Meeting”) to be held at 8:00 a.m. Eastern Time on Wednesday, May 21, 2025. This supplement (the “Supplement”) to the Proxy Statement, supplements and amends the Proxy Statement as filed. The sole purpose of this Supplement is to correct a typographical error on page 87 of the Proxy Statement in reporting the shares of common stock outstanding as of March 24, 2025, as set forth below under the heading “Correction to the Proxy Statement.” CORRECTION TO THE PROXY STATEMENT The first paragraph on page 87 of the Proxy Statement under the heading “Stock Ownership of Directors and Executive Officers” is amended and restated in its entirety to read as follows (correction is marked, with new text bold and underlined and deleted text bold and strikethrough). The following table sets forth certain information with respect to the beneficial ownership of the Company’s common stock as of March 24, 2025 (unless otherwise indicated) held by (i) the NEOs, (ii) each director and nominee for director, (iii) all directors and executive officers of the Company as a group and (iv) all persons or groups believed by the Company to be the beneficial owners of more than 5% of its outstanding common stock,